Variant report
Variant | rs12489885 |
---|---|
Chromosome Location | chr3:196244846-196244847 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:38)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:38 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | SRF | chr3:196244539-196245359 | ECC-1 | luminal epithelium: | n/a | chr3:196244897-196244915 |
2 | MAX | chr3:196244809-196245053 | K562 | blood: | n/a | n/a |
3 | MAX | chr3:196244664-196245426 | ECC-1 | luminal epithelium: | n/a | n/a |
4 | SRF | chr3:196244638-196245263 | ECC-1 | luminal epithelium: | n/a | chr3:196244897-196244915 |
5 | MAX | chr3:196244834-196245076 | Hela-S3 | cervix: | n/a | n/a |
6 | TCF12 | chr3:196244277-196245250 | ECC-1 | luminal epithelium: | n/a | n/a |
7 | USF1 | chr3:196244811-196245160 | ECC-1 | luminal epithelium: | n/a | n/a |
8 | MYC | chr3:196244826-196245071 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | YY1 | chr3:196244788-196245070 | K562 | blood: | n/a | chr3:196244904-196244916 |
10 | FOS | chr3:196244824-196245024 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | CEBPB | chr3:196244624-196245211 | ECC-1 | luminal epithelium: | n/a | n/a |
12 | ELK1 | chr3:196244783-196245247 | K562 | blood: | n/a | n/a |
13 | FOXA1 | chr3:196244752-196245053 | T-47D | breast: | n/a | n/a |
14 | POU2F2 | chr3:196244719-196245200 | GM12878 | blood: | n/a | chr3:196245014-196245027 |
15 | SRF | chr3:196244796-196244981 | K562 | blood: | n/a | chr3:196244897-196244915 |
16 | SRF | chr3:196244788-196244983 | HepG2 | liver: | n/a | chr3:196244897-196244915 |
17 | SRF | chr3:196244814-196244986 | GM12878 | blood: | n/a | chr3:196244897-196244915 |
18 | SRF | chr3:196244756-196245080 | K562 | blood: | n/a | chr3:196244897-196244915 |
19 | NFIC | chr3:196244569-196245403 | ECC-1 | luminal epithelium: | n/a | n/a |
20 | CEBPB | chr3:196244764-196245090 | Hela-S3 | cervix: | n/a | n/a |
21 | SRF | chr3:196244839-196244975 | GM12878 | blood: | n/a | chr3:196244897-196244915 |
22 | TCF12 | chr3:196244539-196245288 | ECC-1 | luminal epithelium: | n/a | n/a |
23 | ELK1 | chr3:196244805-196245111 | Hela-S3 | cervix: | n/a | n/a |
24 | MAX | chr3:196244730-196245059 | K562 | blood: | n/a | n/a |
25 | ELK4 | chr3:196244738-196245078 | Hela-S3 | cervix: | n/a | n/a |
26 | RAD21 | chr3:196244200-196244956 | Hela-S3 | cervix: | n/a | n/a |
27 | CEBPB | chr3:196244757-196245119 | K562 | blood: | n/a | n/a |
28 | SRF | chr3:196244771-196244977 | GM12878 | blood: | n/a | chr3:196244897-196244915 |
29 | MYC | chr3:196244815-196245017 | K562 | blood: | n/a | n/a |
30 | JUN | chr3:196243852-196246433 | K562 | blood: | n/a | chr3:196246149-196246162 |
31 | SRF | chr3:196244761-196244991 | HepG2 | liver: | n/a | chr3:196244897-196244915 |
32 | FOXA1 | chr3:196244753-196244988 | ECC-1 | luminal epithelium: | n/a | n/a |
33 | NFIC | chr3:196244502-196245352 | ECC-1 | luminal epithelium: | n/a | n/a |
34 | YY1 | chr3:196244724-196245086 | H1-hESC | embryonic stem cell: | n/a | chr3:196244904-196244916 |
35 | SRF | chr3:196244784-196244998 | GM12878 | blood: | n/a | chr3:196244897-196244915 |
36 | FOXA1 | chr3:196244668-196245024 | T-47D | breast: | n/a | n/a |
37 | POU2F2 | chr3:196244772-196245186 | GM12891 | blood: | n/a | chr3:196245014-196245027 |
38 | YY1 | chr3:196244749-196245186 | H1-hESC | embryonic stem cell: | n/a | chr3:196244904-196244916 |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SMCO1 | TF binding region |
ENSG00000072274 | Chromatin interaction |
ENSG00000273013 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs11185544 | 0.81[AMR][1000 genomes];0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs11711594 | 0.89[ASN][1000 genomes] |
rs11711952 | 0.95[ASN][1000 genomes] |
rs11714694 | 0.87[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs11920455 | 0.92[ASN][1000 genomes] |
rs12494859 | 0.89[ASN][1000 genomes] |
rs12495687 | 0.89[ASN][1000 genomes] |
rs2086891 | 0.87[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs2101285 | 0.87[EUR][1000 genomes] |
rs2341334 | 0.92[ASN][1000 genomes] |
rs2341399 | 0.94[EUR][1000 genomes] |
rs3964310 | 0.87[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs4488870 | 0.95[ASN][1000 genomes] |
rs56144237 | 0.92[ASN][1000 genomes] |
rs57365032 | 0.89[ASN][1000 genomes] |
rs62410583 | 0.89[ASN][1000 genomes] |
rs6583317 | 0.89[ASN][1000 genomes] |
rs6583318 | 0.89[ASN][1000 genomes] |
rs66588136 | 0.89[ASN][1000 genomes] |
rs6765975 | 0.95[ASN][1000 genomes] |
rs6775794 | 0.89[ASN][1000 genomes] |
rs6775806 | 0.95[ASN][1000 genomes] |
rs6780633 | 0.95[ASN][1000 genomes] |
rs6780856 | 0.95[ASN][1000 genomes] |
rs6799694 | 0.89[ASN][1000 genomes] |
rs6799697 | 0.82[ASN][1000 genomes] |
rs6803397 | 0.87[ASN][1000 genomes] |
rs6803596 | 0.82[ASN][1000 genomes] |
rs6807081 | 0.84[ASN][1000 genomes] |
rs6807097 | 0.87[ASN][1000 genomes] |
rs6810083 | 0.84[ASN][1000 genomes] |
rs73219653 | 0.87[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs73219654 | 0.87[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs73219660 | 0.95[ASN][1000 genomes] |
rs7614249 | 0.81[ASN][1000 genomes] |
rs7615547 | 0.95[ASN][1000 genomes] |
rs7623111 | 0.95[ASN][1000 genomes] |
rs7623224 | 0.89[ASN][1000 genomes] |
rs7629990 | 0.87[ASN][1000 genomes] |
rs7651365 | 0.81[ASN][1000 genomes] |
rs9811428 | 0.84[ASN][1000 genomes] |
rs9818507 | 0.95[ASN][1000 genomes] |
rs9839347 | 0.95[ASN][1000 genomes] |
rs9840938 | 0.95[ASN][1000 genomes] |
rs9849530 | 0.95[ASN][1000 genomes] |
rs9854347 | 0.85[ASN][1000 genomes] |
rs9858251 | 0.89[ASN][1000 genomes] |
rs9870613 | 0.89[ASN][1000 genomes] |
rs9880563 | 0.89[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1003194 | chr3:195960270-196342423 | Strong transcription Weak transcription Enhancers Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 64 gene(s) | inside rSNPs | diseases |
2 | nsv536894 | chr3:195960270-196342423 | Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS Bivalent/Poised TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 64 gene(s) | inside rSNPs | diseases |
3 | nsv1003066 | chr3:196098763-196414159 | Flanking Active TSS Strong transcription Weak transcription Active TSS Enhancers Bivalent Enhancer Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
4 | esv2752687 | chr3:196147690-196286690 | Flanking Active TSS Enhancers Strong transcription Weak transcription Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 28 gene(s) | inside rSNPs | diseases |
5 | nsv948681 | chr3:196148055-197007546 | Weak transcription Strong transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 84 gene(s) | inside rSNPs | diseases |
6 | nsv1010483 | chr3:196210054-196319543 | Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 29 gene(s) | inside rSNPs | diseases |
7 | nsv536896 | chr3:196210054-196319543 | Strong transcription Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 29 gene(s) | inside rSNPs | diseases |
8 | nsv1014692 | chr3:196242249-196531824 | Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Strong transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 48 gene(s) | inside rSNPs | diseases |
9 | esv2763750 | chr3:196242261-196278366 | Active TSS Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:196239400-196245000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr3:196242600-196245200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
3 | chr3:196242600-196246400 | Enhancers | K562 | blood |
4 | chr3:196244000-196245400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr3:196244000-196245400 | Enhancers | HMEC | breast |
6 | chr3:196244200-196246800 | Enhancers | Hela-S3 | cervix |
7 | chr3:196244400-196245600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
8 | chr3:196244800-196245200 | Active TSS | iPS-18 Cell Line | embryonic stem cell |
9 | chr3:196244800-196247600 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |